Cargando…
Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial
AIMS: Current follow-up for head and neck cancer (HNC) is ineffective, expensive and fails to address patients' needs. The PETNECK2 trial will compare a new model of patient-initiated follow-up (PIFU) with routine scheduled follow-up. This article reports UK clinicians' views about HNC fol...
Autores principales: | Lorenc, A., Wells, M., Fulton-Lieuw, T., Nankivell, P., Mehanna, H., Jepson, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950325/ https://www.ncbi.nlm.nih.gov/pubmed/34862101 http://dx.doi.org/10.1016/j.clon.2021.11.010 |
Ejemplares similares
-
Exploring the views of patients' and their family about patient‐initiated follow‐up in head and neck cancer: A mixed methods study
por: Lorenc, Ava, et al.
Publicado: (2022) -
Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma
por: Payne, Karl, et al.
Publicado: (2022) -
Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
por: Payne, Karl, et al.
Publicado: (2019) -
A systematic review of the effectiveness of patient‐initiated follow‐up after cancer
por: Dretzke, Janine, et al.
Publicado: (2023) -
Systematic review of patients’ and healthcare professionals’ views on patient‐initiated follow‐up in treated cancer patients
por: Dretzke, Janine, et al.
Publicado: (2023)